🏥 Health
·
CNBC
·
Every Cure's Drug Repurposing Strategy Could Transform Rare Disease Treatment
David Fajgenbaum and colleagues launched the non-profit Every Cure, built around a drug repurposing strategy that challenges the traditional pharmaceutical research model. Rather than developing new drugs, the organization explores existing medications for new uses. This approach could significantly change how rare diseases are treated.
When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that challenged the traditional research model.